Senseonics Holdings Inc (NYSEAMERICAN:SENS) was the target of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 4,635,391 shares, an increase of 17.5% from the January 12th total of 3,946,300 shares. Currently, 9.6% of the shares of the company are short sold. Based on an average daily volume of 667,199 shares, the short-interest ratio is currently 6.9 days.

Separately, Canaccord Genuity reissued a “buy” rating on shares of Senseonics in a research report on Wednesday, November 1st.

Shares of Senseonics (NYSEAMERICAN SENS) opened at $2.51 on Wednesday. Senseonics has a 1 year low of $1.26 and a 1 year high of $3.67. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.81 and a current ratio of 2.93. The stock has a market cap of $352.88 and a price-to-earnings ratio of -5.16.

In other Senseonics news, major shareholder Peter J. Barris sold 139,645 shares of Senseonics stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $2.63, for a total value of $367,266.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 34.10% of the company’s stock.

Several hedge funds have recently modified their holdings of the company. Raymond James Financial Services Advisors Inc. grew its position in shares of Senseonics by 38.9% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 487,175 shares of the company’s stock valued at $1,296,000 after acquiring an additional 136,425 shares during the period. Goldman Sachs Group Inc. bought a new stake in shares of Senseonics during the 2nd quarter valued at $276,000. Susquehanna International Group LLP bought a new stake in shares of Senseonics during the 2nd quarter valued at $155,000. Citadel Advisors LLC bought a new stake in shares of Senseonics during the 3rd quarter valued at $194,000. Finally, Perceptive Advisors LLC bought a new stake in shares of Senseonics during the 3rd quarter valued at $160,000. 30.66% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another publication, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2018/02/14/senseonics-holdings-inc-sens-sees-large-growth-in-short-interest.html.

Senseonics Company Profile

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.